One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

The mass layoffs of federal workers under Health Secretary Robert F. Kennedy Jr. have impaired data-gathering on critical ...

Canadian health experts warn the fallout from thousands of job cuts at the U.S. Food and Drug Administration on April 1 could ...

The Trump administration’s remaking of HHS — in a matter of weeks — is sparking basic questions about how parts of the agency and those it oversees can continue to function.

Far as he was from Washington, D.C., as Health and Human Services Secretary Robert F. Kennedy Jr. hiked to the top of a ...

Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical ...

Layoffs at the Food and Drug Administration are expected to reduce the FDA's workforce by 20%. Susan Mayne, former director ...

The Division of Policy Development in the Office of Generic Drug Policy, which was created more than a decade ago, was responsible for a host of activities that were central to ensuring generic drugs ...

The summary presents key developments affecting the health sector, including disruptions in the FDA due to Trump's layoffs, ...

Anyone in the US who’s depended on a respirator to provide protection against dust, smoke, mold or airborne viruses has likely relied on a small but mighty agency within the US Centers for Disease ...

The FDA is slated to lose 3,500 employees under Secretary of Health ... task force were quickly re-hired after the potential impact of their departures on product reviews became apparent.